Samuels Noah, Grbic John T, Saffer Aron J, Wexler Isaiah D, Williams Ray C
Center for Integrative Complementary Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
Compend Contin Educ Dent. 2012 Mar;33(3):204-6, 208-11.
Gingivitis is a chronic inflammatory condition, resulting from gingival bacteria and bacterial byproducts. Antiplaque oral rinses reduce inflammation by removing or inhibiting plaque formation. The purpose of this pilot study was to examine the anti-inflammatory effects of HM-302, a mouth rinse based on natural products, on gingival inflammation.
A prospective, double-blinded, randomized parallel-group controlled trial involving 62 patients was conducted to assess efficacy and safety. During a 2-week period with no dental hygiene, subjects were randomized to receive either the study rinse (HM-302); a cetylpyridinium chloride (CPC) rinse; an essential oils (EO) rinse; or a water-only preparation. The gingival index (GI), plaque index (PI), and number of bleeding sites were measured at baseline and at the end of the study period.
Progression of gingival inflammation resulting from lack of dental hygiene was lowest in patients treated with the HM-302 rinse, and was significantly less marked than in patients treated with the water-only preparation. When compared to the CPC and EO treatments, HM-302 was the only mouth rinse that was significantlybetter than the control, with respect to both the change in absolute GI scores (p = .006) and to the percent increase in GI scores (p = .012). No serious adverse effects were noted in any of the study groups.
HM-302 is a safe and effective treatment for preventing the development of gingival inflammation in an experimental gingivitis model. Further research is needed to evaluate its long-term effects.
牙龈炎是一种慢性炎症性疾病,由牙龈细菌及细菌副产物引起。抗牙菌斑口腔含漱液通过清除或抑制牙菌斑形成来减轻炎症。本初步研究的目的是检验基于天然产物的含漱液HM - 302对牙龈炎症的抗炎作用。
进行了一项前瞻性、双盲、随机平行组对照试验,纳入62例患者以评估疗效和安全性。在为期2周不进行口腔卫生护理的期间,受试者被随机分组,分别接受研究含漱液(HM - 302)、西吡氯铵(CPC)含漱液、精油(EO)含漱液或仅用水的制剂。在基线和研究期末测量牙龈指数(GI)、菌斑指数(PI)及出血部位数量。
在未进行口腔卫生护理导致的牙龈炎症进展方面,接受HM - 302含漱液治疗的患者中炎症进展最低,且明显低于仅接受用水制剂治疗的患者。与CPC和EO治疗相比,HM - 302是唯一在绝对GI评分变化(p = .006)和GI评分增加百分比(p = .012)两方面均显著优于对照的含漱液。在任何研究组中均未观察到严重不良反应。
在实验性牙龈炎模型中,HM - 302是预防牙龈炎症发生的一种安全有效的治疗方法。需要进一步研究以评估其长期效果。